Al population women.Table 3. Comparison of sexual impairment rates between women with systemic sclerosis and women from a UK general population sample, stratified by age and marital status.Married CSRG Age Group 18?9 30?9 40?9 50?9 60?9 70+ Total N 4 12 71 92 62 11 252 N ( ) Impaired 3 (75) 7 (58) 36 (51) 60 (65) 45 (73) 8 (73) 159 (63) UK N 5 81 119 220 140 34 599 N ( ) Impaired 4 (80) 23 (28) 41 (34) 112 (51) 79 (56) 26 (76) 285 (48) Rate Ratio 0.94 2.05 1.47 1.28 1.29 0.95 1.33 95 CI 0.46?.92 1.14?.71 1.05?.06 1.05?.56 1.04?.59 0.63?.43 1.17?.Non-Married CSRG N 2 7 14 9 10 2 44 N ( ) Impaired 0 (0) 5 (71) 5 (36) 6 (67) 5 (50) 1 (50) 22 (50) UK N 8 52 88 117 78 14 357 N ( 
) Impaired 1 (13) 14 (27) 16 (18) 52 (44) 42 (54) 10 (71) 135 (38) Rate Ratio 0 2.65 1.96 1.50 0.93 0.70 1.32 95 CI —-1.39?.07 0.86?.51 0.91?.48 0.48?.78 0.17?.91 0.96?.doi:10.1371/journal.pone.Eledoisin supplier 0052129.tFemale Sexual Functioning in Systemic SclerosisTable 4. Comparison of FSFI domain scores between sexually active women with systemic sclerosis Patients and sexually active women from a UK general population sample; unadjusted and adjusted for total FSFI score.Unadjusted Domain Scores FSFI Domain Desire Arousal Lubrication Orgasm Pain Mean Difference (UK ?CSRG) 0.29 0.22 0.94 0.36 0.75 P value ,0.001 0.014 ,0.001 0.001 ,0.001 Hedge’s g 0.25 0.16 0.66 0.25 0.Domain Scores, Adjusted for Total FSFI Score Mean Difference (UK ?CSRG) 20.11 20.31 0.40 20.19 0.21 P value 0.054 ,0.001 ,0.001 0.003 0.012 Hedge’s g 20.13 20.38 0.43 20.20 0.(CSRG Sample: N = 296; UK Sample: N = 956). doi:10.1371/journal.pone.0052129.tIn SSc, several previous studies have suggested that rates of sexual impairment might be high using different instruments and methods, and have suggested factors that may be related [11,12,19?3]. No previous studies, however, used a validated measure to compare domains of sexual function that may be problematic for women with SSc. The finding of the present study that lubrication is a key problem driving impairment in SSc is consistent with literature suggesting that Eledoisin web vaginal dryness is commonly reported among women with SSc, and is linked to sexual impairment [11,13,23]. In addition, the finding that pain was also an important factor driving impairment in SSc is consistent with previous research, which found that over 60 
of sexually active female SSc patients report experiencing pain during sexual activity, and almost 40 report experiencing pain after sexual activity [12]. In addition to symptomatic treatments for SSc symptoms, including vasodilators for Raynaud’s syndrome and finger ulcers, proton pump inhibitors and promotility agents for gastric reflux, and general analgesia (e.g., acetaminophen, anti-inflammatories when not contra-indicated, and narcotics if necessary), several authors have suggested steps that women with SSc can take that may reduce their pain and discomfort during sexual activity [11,13,14]. For instance, a water-based lubricant may be useful to reduce vaginal dryness and dyspareunia [11,13,14,19,20,23]. A warm bath before sexual activities, attempting alternative sexual positions, and using pillows may reduce the effects of painful joints [11,14,20,22]. Good communication during sexual activity hasalso been emphasized so that partners are aware of what is pleasurable and painful [14]. It is also possible that sexual function could be improved through range of motion exercises to reduce joint pain and stiffness prior to sexual activity, ma.Al population women.Table 3. Comparison of sexual impairment rates between women with systemic sclerosis and women from a UK general population sample, stratified by age and marital status.Married CSRG Age Group 18?9 30?9 40?9 50?9 60?9 70+ Total N 4 12 71 92 62 11 252 N ( ) Impaired 3 (75) 7 (58) 36 (51) 60 (65) 45 (73) 8 (73) 159 (63) UK N 5 81 119 220 140 34 599 N ( ) Impaired 4 (80) 23 (28) 41 (34) 112 (51) 79 (56) 26 (76) 285 (48) Rate Ratio 0.94 2.05 1.47 1.28 1.29 0.95 1.33 95 CI 0.46?.92 1.14?.71 1.05?.06 1.05?.56 1.04?.59 0.63?.43 1.17?.Non-Married CSRG N 2 7 14 9 10 2 44 N ( ) Impaired 0 (0) 5 (71) 5 (36) 6 (67) 5 (50) 1 (50) 22 (50) UK N 8 52 88 117 78 14 357 N ( ) Impaired 1 (13) 14 (27) 16 (18) 52 (44) 42 (54) 10 (71) 135 (38) Rate Ratio 0 2.65 1.96 1.50 0.93 0.70 1.32 95 CI —-1.39?.07 0.86?.51 0.91?.48 0.48?.78 0.17?.91 0.96?.doi:10.1371/journal.pone.0052129.tFemale Sexual Functioning in Systemic SclerosisTable 4. Comparison of FSFI domain scores between sexually active women with systemic sclerosis Patients and sexually active women from a UK general population sample; unadjusted and adjusted for total FSFI score.Unadjusted Domain Scores FSFI Domain Desire Arousal Lubrication Orgasm Pain Mean Difference (UK ?CSRG) 0.29 0.22 0.94 0.36 0.75 P value ,0.001 0.014 ,0.001 0.001 ,0.001 Hedge’s g 0.25 0.16 0.66 0.25 0.Domain Scores, Adjusted for Total FSFI Score Mean Difference (UK ?CSRG) 20.11 20.31 0.40 20.19 0.21 P value 0.054 ,0.001 ,0.001 0.003 0.012 Hedge’s g 20.13 20.38 0.43 20.20 0.(CSRG Sample: N = 296; UK Sample: N = 956). doi:10.1371/journal.pone.0052129.tIn SSc, several previous studies have suggested that rates of sexual impairment might be high using different instruments and methods, and have suggested factors that may be related [11,12,19?3]. No previous studies, however, used a validated measure to compare domains of sexual function that may be problematic for women with SSc. The finding of the present study that lubrication is a key problem driving impairment in SSc is consistent with literature suggesting that vaginal dryness is commonly reported among women with SSc, and is linked to sexual impairment [11,13,23]. In addition, the finding that pain was also an important factor driving impairment in SSc is consistent with previous research, which found that over 60 of sexually active female SSc patients report experiencing pain during sexual activity, and almost 40 report experiencing pain after sexual activity [12]. In addition to symptomatic treatments for SSc symptoms, including vasodilators for Raynaud’s syndrome and finger ulcers, proton pump inhibitors and promotility agents for gastric reflux, and general analgesia (e.g., acetaminophen, anti-inflammatories when not contra-indicated, and narcotics if necessary), several authors have suggested steps that women with SSc can take that may reduce their pain and discomfort during sexual activity [11,13,14]. For instance, a water-based lubricant may be useful to reduce vaginal dryness and dyspareunia [11,13,14,19,20,23]. A warm bath before sexual activities, attempting alternative sexual positions, and using pillows may reduce the effects of painful joints [11,14,20,22]. Good communication during sexual activity hasalso been emphasized so that partners are aware of what is pleasurable and painful [14]. It is also possible that sexual function could be improved through range of motion exercises to reduce joint pain and stiffness prior to sexual activity, ma.
